Literature DB >> 24512491

Association between metabolic syndrome and incident fractures in Korean men: a 3-year follow-up observational study using national health insurance claims data.

Seung Hun Lee1, Seunghee Baek, Seong Hee Ahn, Seon Ha Kim, Min-Woo Jo, Sung Jin Bae, Hong-Kyu Kim, Jaewon Choe, Gyung-Min Park, Young-Hak Kim, Jung-Min Koh, Beom-Jun Kim, Ghi Su Kim.   

Abstract

CONTEXT: Although the prevalence of both metabolic syndrome (MetS) and fractures increases with advancing age, studies on possible associations between these conditions in men are limited and the results are inconsistent.
OBJECTIVE: The objective of the study was to clarify the impact of MetS on the male risk of incident fractures. DESIGN AND
SETTING: This was a large, longitudinal study with an average 3-year follow-up period. PARTICIPANTS: Korean men (n = 16 078) aged 50 years or older who had undergone comprehensive routine health examinations participated in the study. MAIN OUTCOME MEASURES: Incident fractures found after baseline examinations were identified using selected International Classification of Diseases, tenth revision, codes in the nationwide claims database of the Health Insurance Review and Assessment Service of Korea.
RESULTS: In total, 158 men (1.0%) developed incident fractures. The fracture event rates for subjects with and without MetS were 26.2 and 35.7 per 10 000 person-years, respectively. After adjustment for potential confounders, subjects with MetS had a much lower risk of incident fractures than subjects without MetS (hazard ratio 0.662, 95% confidence interval 0.445-0.986). Furthermore, subjects with three and four or more MetS components had a 49.4% and 50.4% lower risk, respectively, of incident fractures compared with the subjects without any MetS components. Importantly, additional adjustment for body mass index eliminated the statistical significance of these associations.
CONCLUSION: Our current results indicate that the beneficial effects of MetS in reducing fracture risk could be explained by the general obesity that accompanies MetS, although other related factors, such as greater padding effect, peripheral aromatization, or adipokine changes, may also contribute.

Entities:  

Mesh:

Year:  2014        PMID: 24512491     DOI: 10.1210/jc.2013-3608

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Abdominal Obesity and Risk of Hip Fracture: A Systematic Review and Meta-Analysis of Prospective Studies.

Authors:  Omid Sadeghi; Parvaneh Saneei; Morteza Nasiri; Bagher Larijani; Ahmad Esmaillzadeh
Journal:  Adv Nutr       Date:  2017-09-15       Impact factor: 8.701

2.  The Association of Lipids and Lipoproteins with Hip Fracture Risk: The Cardiovascular Health Study.

Authors:  Joshua I Barzilay; Petra Buzkova; Lewis H Kuller; Jane A Cauley; Howard A Fink; Kerry Sheets; John A Robbins; Laura D Carbone; Rachel E Elam; Kenneth J Mukamal
Journal:  Am J Med       Date:  2022-06-06       Impact factor: 5.928

Review 3.  Does metabolic syndrome increase the risk of fracture? A systematic review and meta-analysis.

Authors:  Mazyar Babagoli; Mohammad Soleimani; Soroush Baghdadi; Mehrdad Sheikh Vatan; Seyyed Hossein Shafiei
Journal:  Arch Osteoporos       Date:  2022-08-31       Impact factor: 2.879

4.  Triglyceride Levels and Fracture Risk in Midlife Women: Study of Women's Health Across the Nation (SWAN).

Authors:  Po-Yin Chang; Ellen B Gold; Jane A Cauley; Wesley O Johnson; Carrie Karvonen-Gutierrez; Elizabeth A Jackson; Kristine M Ruppert; Jennifer S Lee
Journal:  J Clin Endocrinol Metab       Date:  2016-06-13       Impact factor: 5.958

5.  2013 ACC/AHA versus 2004 NECP ATP III Guidelines in the Assignment of Statin Treatment in a Korean Population with Subclinical Coronary Atherosclerosis.

Authors:  Chang Hee Jung; Min Jung Lee; Yu Mi Kang; Dong Hyun Yang; Joon-Won Kang; Eun Hee Kim; Duk-Woo Park; Joong-Yeol Park; Hong-Kyu Kim; Woo Je Lee
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

6.  The Population-Based Risk of Need for Coronary Revascularization According to the Presence of Type 2 Diabetes Mellitus and History of Coronary Heart Disease in the Korean Population.

Authors:  Chang Hee Jung; Gi Hyeon Seo; Sunghwan Suh; Ji Cheol Bae; Mee Kyoung Kim; You-Cheol Hwang; Jae Hyeon Kim; Byung-Wan Lee
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

7.  Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan.

Authors:  Daisuke Inoue; Ryoichi Muraoka; Ryo Okazaki; Yoshiki Nishizawa; Toshitsugu Sugimoto
Journal:  Calcif Tissue Int       Date:  2015-10-14       Impact factor: 4.333

8.  Metabolic factors and hip fracture risk in a large Austrian cohort study.

Authors:  Erlangga Dominic; Wolfgang Brozek; Raphael Simon Peter; Ella Fromm; Hanno Ulmer; Kilian Rapp; Hans Concin; Gabriele Nagel
Journal:  Bone Rep       Date:  2020-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.